Additionally, in GENT2 using the platform “HG-U133_Plus_2”, significantly increased COL4A1 expression was also observed in all the examined tumor tissues from adipose, adrenal gland, bladder, blood, brain, colon, head and neck, kidney, liver, lung, oral, ovary, pharynx, skin, stomach, teeth, testis, thyroid, tongue, uterus, and vulva tumors, except for endometrium tumors in comparison to their normal counterpart tissues (Figure 1b). This evidence concerns the gene COL4A1 and cervical carcinoma.